Christiane Wolter-Reeh

Title: Christiane Wolter-Reeh: Innovator in Pharmaceutical Advancements

Introduction

Christiane Wolter-Reeh is a notable inventor based in Holm, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in enhancing the bioavailability of pharmaceutical substances. With a total of 2 patents, her work focuses on methods that allow pharmaceutical substances to effectively permeate the blood-brain barrier.

Latest Patents

Wolter-Reeh's latest patents include a method for producing prodrugs from amidoxime and N-hydroxyguanidine carboxylic acid esters. This invention aims to improve the bioavailability of pharmaceutical substances that contain amidine, guanidine, N-hydroxyamidine (amidoxime), or N-hydroxyguanidine functions. Additionally, she has developed amino acid derivatives used as pharmaceutical substances, which also focus on enhancing bioavailability and facilitating the passage of these substances through the blood-brain barrier.

Career Highlights

Throughout her career, Christiane has worked with various companies, including Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG and Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG. Her innovative approaches have positioned her as a key figure in pharmaceutical research and development.

Collaborations

Some of her notable coworkers include Bernd Clement and Helen Schenk, who have collaborated with her on various projects in the pharmaceutical sector.

Conclusion

Christiane Wolter-Reeh's contributions to pharmaceutical innovations demonstrate her commitment to improving drug efficacy and accessibility. Her patents reflect a deep understanding of complex biochemical processes, making her a valuable asset to the field of pharmaceuticals.